Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Gross Profit Margin (Quarterly): 61.31% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.31% |
| June 30, 2024 | 77.25% |
| March 31, 2024 | 45.85% |
| December 31, 2023 | -5.67% |
| September 30, 2023 | -105.3% |
| June 30, 2023 | -556.2% |
| Date | Value |
|---|---|
| March 31, 2023 | -146.4% |
| December 31, 2022 | -20.43% |
| September 30, 2022 | 7.89% |
| June 30, 2022 | 59.50% |
| March 31, 2022 | -286.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-556.2%
Minimum
Jun 2023
77.25%
Maximum
Jun 2024
-79.00%
Average
-5.67%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Procaps Group SA | -- |
| Johnson & Johnson | 69.01% |
| Pfizer Inc | 70.27% |
| Rigel Pharmaceuticals Inc | 85.49% |
| NovaBay Pharmaceuticals Inc | 65.26% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -41.88% |
| Return on Invested Capital | -127.4% |
| Profit Margin (Quarterly) | -11.07% |
| Operating Margin (Quarterly) | 12.37% |
| Return on Net Operating Assets | -72.97% |